Home

We are a consortium of physicians and scientists promoting phage therapy as a response to the alarming global increase in infections with antibiotic resistant bacteria.
Established in 2020, the Phage4-1Health Consortium has hosted EU phage researchers in regular monthly meetings and organized get-togethers at phage conferences. Our organizational concept is based on a flat hierarchy, openness, as well as fast and uncomplicated communication.

As a result, we were able to advise EU patients on safe phage therapy and provide our expertise to patients and phage suppliers before, during, and after phage therapy. We support innovative solutions for phage applications of highest quality, and have contributed to non-binding guidelines on safe phage therapy in Germany and the EU. Landmark papers on these topics were published by members of the Phage Consortium.

Our aim is to connect phage experts worldwide, obtain EU-wide scientific grants, and publish peer-reviewed publications on translational topics related to phage therapy and research. Our educational short lectures inform the consortium members on different phage-related aspects.

When regulatory conditions for phage therapy are particularly challenging, such as in Germany, we have advised on regulatory guidelines in consultation with the Federal Institute for Drugs and Medical Devices (BfArM) and the respective state authorities in Germany.

All of these efforts continue thanks to our dedicated consortium members, highly valued interdisciplinary cooperations, and a number of successful applications for EU funding grants.

About this website

This site uses cookies. Using the site you agree to our terms, conditions, and data protection protocols.